Zobrazeno 1 - 10
of 688
pro vyhledávání: '"Francis, GS"'
Autor:
Psotka, MA, Gottlieb, SS, Francis, GS, Allen, LA, Teerlink, JR, Adams, KF, Rosano, GMC, Lancellotti, P
The term "inotrope" is familiar and intimately connected with pharmaceuticals clinically used for treatment of low cardiac output with cardiogenic shock. Traditional inotropic agents exert their effect by modulating calcium signaling in the myocardiu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::35839cbe5c42d7d5d712958a80dee9e5
https://openaccess.sgul.ac.uk/id/eprint/111194/1/1-s2.0-S0735109719344961-main.pdf
https://openaccess.sgul.ac.uk/id/eprint/111194/1/1-s2.0-S0735109719344961-main.pdf
Autor:
Holmes, DR, Mack, MJ, Kaul, S, Agnihotri, A, Alexander, KP, Bailey, SR, Calhoon, JH, Carabello, BA, Desai, MY, Edwards, FH, Francis, GS, Gardner, TJ, Kappetein, Arie-Pieter, Linderbaum, JA, Mukherjee, C, Mukherjee, D, Otto, CM, Ruiz, CE, Sacco, RL, Smith, D, Thomas, JD, Harrington, RA, Bhatt, L, Ferrari, VA, Fisher, JD, Garcia, MJ, Gentile, F, Gilson, MF, Hernandez, A, Jacobs, AK, Moliterno, DJ, Weitz, HH
Publikováno v:
Catheterization and Cardiovascular Interventions, 79, 1023-1082. Wiley-Liss Inc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::3aff04274701b5a4fd863b14d0461b2a
https://pure.eur.nl/en/publications/5f36950f-0f1c-4cdf-9b65-6f9fc3042634
https://pure.eur.nl/en/publications/5f36950f-0f1c-4cdf-9b65-6f9fc3042634
An episode of acute heart failure syndromes (AHFS) can be defined as a rapid or gradual onset of signs and symptoms of heart failure (HF) that result in hospital admission and can arise from a variety of pathophysiologic mechanisms. This article revi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::04ae5c435d58cf5242e376aa6e84beea
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3097369
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3097369
Autor:
FREEDMAN MS, FRANCIS GS, SANDERS EACM, RICE GPA, O'CONNOR P, DUQUETTE P, METZ L, MURRAY TJ, BOUCHARD J. P, ABRAMSKY O, PELLETIER J, O'BRIEN F, OWIS STUDY GROUP, THE UNIVERSITY OF BRITISH COLUMBIA MSMRI RESEARCH GROUP, COMI , GIANCARLO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::f57e3ee23e2a6e3fad13c540ee3de669
Autor:
Petkau, AJ, White, RA, Ebers, GC, Reder, AT, Sibley, WA, Lublin, FD, Paty, DW, Duquette, P, Girard, M, Despault, L, DuBois, R, Knobler, RL, Kelley, L, Francis, GS, Lapierre, Y, Antel, J, Freedman, M, Hum, S, Greenstein, JI, Mishra, B, Muldoon, J, Whitaker, JN, Evans, BK, Layton, B, Laguna, J, Krikawa, J, Oger, JJ, Kastrukoff, LF, Moore, GRW, Hashimoto, SA, Morrison, W, Nelson, J, Goodin, DS, Massa, SM, Gutteridge, E, Arnason, BGW, Noronha, A, Martia, R, Rice, GPA, Lesaux, J, Johnson, KP, Panitch, HS, Bever, CT, Conway, K, Wallenberg, JC, Bedell, L, van den Noort, S, Weinshenker, B, Weiss, W, Reingold, S, Pachner, A, Taylor, W
Publikováno v:
Multiple Sclerosis. 10(2)
We have analysed dataon exacerbation rates, Expanded Disability Status Scale (EDSS) scores, and lesion burdens using the results of two neutralizing antibody (NAB) assays (CPE and MxA) from the pivotal relapsing i/remitting multiple sclerosis (MS) tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e505dd19c0d8a072526a10982b50375
http://ora.ox.ac.uk/objects/uuid:1df9cc28-54d0-4335-9604-f62f8146dfc6
http://ora.ox.ac.uk/objects/uuid:1df9cc28-54d0-4335-9604-f62f8146dfc6
Autor:
Arnason, BGW, Jacobs, G, Hanlon, M, Clay, BH, Noronha, ABC, Auty, A, Davis, B, Nath, A, Bouchard, JP, Belanger, C, Gosselin, F, Thibault, M, Duquette, P, Bourgoin, P, DuBois, R, Girard, M, Ebers, GC, Rice, GPA, Vandervoort, MK, Francis, GS, Duncan, L, Lapierre, Y, Freedman, MS, Christie, SN, Rabinovitch, HE, Patry, D, Murphy, WF, Peters, S, McGuiness, SD, Murray, TJ, Bhan, V, Maxner, CE, Van Dorpe, R, Oger, JJ, Nelson, J, Morrison, W, Bogle, N, Beall, S, Vorobeychick, G, Hiltbrunner, AV, Bock, J, Lesslauer, W, Li, DKB, Paty, DW, Zhao, GJ, Grp, LMSS, Grp, UBCMSMRIA
Publikováno v:
NEUROLOGY. 53(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::8a91820871f8ff88883cc3e5b6540155
http://ora.ox.ac.uk/objects/uuid:2f9e0dcd-42bb-4059-b1cc-1360162dde02
http://ora.ox.ac.uk/objects/uuid:2f9e0dcd-42bb-4059-b1cc-1360162dde02
Autor:
Duquette, P, Girard, M, Dubois, R, Kobler, RL, Lublin, F, Kelley, L, Francis, GS, Freedman, M, Greenstein, JI, Mishra, B, DeLillio, N, Whitaker, J, Layton, B, Sibley, WA, Laguna, J, Krikawa, J, Paty, DW, Oger, JJ, Kastrukoff, LF, Morrison, W, Nelson, J, Goodin, D, Massa, SM, Gutteridge, E, Arnason, BGW, Noronha, A, Reder, AT, Martia, R, Ebers, GC, Rice, GPA, Lesaux, J, Johnson, KP, Panitch, HS, Bever, CT, Conway, K, Li, DKB, Tanton, EL, Zhao, GJ, Flak, B, Riddebough, A, Cover, K, Rhodes, B, Cook, A, Smith, K, Costley, L, Renneberg, S, Shaw, T, Genton, M, vandenNoort, S, Weinshenker, B, Weiss, W, Reingold, S, Taylor, W, Wallenberg, JC, Bedell, L, Lublin, FD
Publikováno v:
NEUROLOGY. 47(4)
Evidence of diminution of therapeutic efficacy in 35% of interferon beta-1b (IFNB)-treated multiple sclerosis (MS) patients who developed neutralizing antibodies (NABs) led to extensive study of the effects of NABs on therapeutic benefits, side effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ce92003e0f086f1376f1c63261eacbb
http://ora.ox.ac.uk/objects/uuid:c8aa5525-fea1-4ba7-ae06-babecb356304
http://ora.ox.ac.uk/objects/uuid:c8aa5525-fea1-4ba7-ae06-babecb356304
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.